Literature DB >> 7477413

[Glycolipids of the cell surface--biochemistry of their decomposition].

K Sandhoff1, T Kolter.   

Abstract

Glycosphingolipids (GSL) form cell-type-specific patterns on the surface of eukaryotic cells. For the maintenance of these patterns, biosynthesis, intracellular transport, and degradation of GSL are thought to proceed in a coordinated fashion. After transport from the plasma membrane to the lysosomes the degradation of GSL requires protein cofactors to solubilize the membrane-bound substrates of the degradative enzymes. Inborn errors of metabolism leading to defective hydrolases or activator proteins give rise to sphingolipid storage diseases; in some cases the residual enzyme activity can be correlated with the clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477413

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  56 in total

Review 1.  Animal glycosphingolipids as membrane attachment sites for bacteria.

Authors:  K A Karlsson
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  [A cerebrosidesulfatase from swine kidney].

Authors:  E Mehl; H Jatzkewitz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1964

3.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex.

Authors:  M L Phillips; E Nudelman; F C Gaeta; M Perez; A K Singhal; S Hakomori; J C Paulson
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

4.  Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids.

Authors:  K Bock; M E Breimer; A Brignole; G C Hansson; K A Karlsson; G Larson; H Leffler; B E Samuelsson; N Strömberg; C S Edén
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

5.  Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease.

Authors:  J M Penzien; J Kappler; N Herschkowitz; B Schuknecht; P Leinekugel; P Propping; T Tønnesen; H Lou; H Moser; S Zierz
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

6.  Glycosphingolipid specificity of the human sulfatide activator protein.

Authors:  A Vogel; G Schwarzmann; K Sandhoff
Journal:  Eur J Biochem       Date:  1991-09-01

7.  Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.

Authors:  M A Rafi; G de Gala; X L Zhang; D A Wenger
Journal:  Somat Cell Mol Genet       Date:  1993-01

8.  Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene.

Authors:  D Schnabel; M Schröder; W Fürst; A Klein; R Hurwitz; T Zenk; J Weber; K Harzer; B C Paton; A Poulos
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

9.  A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB.

Authors:  M Schröder; D Schnabel; K Suzuki; K Sandhoff
Journal:  FEBS Lett       Date:  1991-09-23       Impact factor: 4.124

View more
  4 in total

Review 1.  Glycosphingolipid degradation and animal models of GM2-gangliosidoses.

Authors:  T Kolter; K Sandhoff
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

2.  DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.

Authors:  Jiangzhou Peng; Baishen Chen; Zhuojian Shen; Heran Deng; Degang Liu; Xuan Xie; Xiangfeng Gan; Xia Xu; Zhiquan Huang; Ju Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Characterizing solution surface loop conformational flexibility of the GM2 activator protein.

Authors:  Jeffery D Carter; Jordan D Mathias; Edwin F Gomez; Yong Ran; Fang Xu; Luis Galiano; Nguyen Q Tran; Peter W D'Amore; Christine S Wright; Dhruva K Chakravorty; Gail E Fanucci
Journal:  J Phys Chem B       Date:  2014-08-26       Impact factor: 2.991

Review 4.  Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease.

Authors:  Wenyue Wang; Sandeep Gopal; Roger Pocock; Zhicheng Xiao
Journal:  Molecules       Date:  2019-12-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.